Validation of the Artificial Intelligence Subsystem of the DDART Medical Device for the Automated Detection of Lesions Compatible With Glaucoma in a Random Sample of Retinal Fundus Photographs
- Sponsor
- Democritus University of Thrace
- Study ID
- NCT07758569
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- color fundus photograph — DIAGNOSTIC_TESTColor retinal fundus photographs will be acquired from: Digital non-mydriatic fundus cameras.
Study Details
Primary Objective To validate the artificial intelligence subsystem of the DDART medical device for the automated detection of lesions compatible with glaucoma in a random sample of retinal fundus photographs.
Key Dates
- First listed
- Aug 11, 2026
- Start date
- Apr 21, 2026
- Status verified
- Apr 2026
- Primary completion
- Apr 19, 2027
- Completion
- Apr 19, 2027
Study Design
- Enrollment
- 2,000 participants (estimated)
Primary Outcome Measure
Validation of the sensitivity and specificity of the artificial intelligence subsystem for AMD detection [ Time Frame: 1 year ]
Central Contacts
- Georgios Labiris+302551030990
Find similar trials
Nationwide
Related Studies
- Novel Glaucoma DiagnosticsRecruiting · Wills Eye · Philadelphia, Pennsylvania
- Stem Cell Ophthalmology Treatment Study IIRecruiting · MD Stem Cells · Westport, Connecticut
- Village-Integrated Eye Worker Trial IIRecruiting · University of California, San Francisco · San Francisco, California
- Pilocarpine Use After Kahook GoniotomyPHASE3 · Recruiting · Montefiore Medical Center · The Bronx, New York